Drug intelligence / Profile preview

Weißdorn

Development stage
Unknown
Lead developer
Robugen
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Weißdorn (Hawthorn extract) is a botanical extract derived from the leaves, flowers, and berries of *Crataegus* species (primarily *Crataegus monogyna* and *Crataegus laevigata*). It is widely used in European phytotherapy as a cardiotonic agent for the treatment of mild heart failure (NYHA class II) and orthostatic circulatory disorders. The extract contains a complex mixture of bioactive compounds, including oligomeric procyanidins (OPCs) and flavonoids (such as vitexin and hyperoside). Weißdorn exerts its therapeutic effects through multiple mechanisms, including the inhibition of the sarcolemmal Na+/K+-ATPase pump (which increases intracellular calcium and enhances myocardial contractility), the inhibition of phosphodiesterase 3 (PDE3), and the activation of endothelial nitric oxide synthase (eNOS), leading to vasodilation and improved coronary blood flow. It is marketed in various formulations, both as a mono-preparation and in combination with other active ingredients like D-camphor.

Brand names
CardiplantCrataegisanCrataeguttFaros
Other names
CrataegusCrataegus extracthawthornhawthorn extract
02

Targets

NOS3 (eNOS)PDE3

Beyond the preview

Go deeper on Weißdorn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weißdorn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call